[Discussion] BPC-157 is doing more work than we give it credit for
BPC-157 is doing more work than we give it credit for. Making the case below, and I expect to lose some of it in the comments. Bought small, tested identity first, and only then thought about anything else. That order felt right. Every claim I could trace in this board went back to about four papers. That was a…
That claim traces back to a single preclinical paper that says something considerably narrower.
[removed by moderator]
preclinical enthusiasm is not clinical evidence
preclinical enthusiasm is not clinical evidence
Adding the standing caveat — research material is not approved for human use, wherever you are.
a fifteen-residue peptide is easy to make and easy to make badly
Purity by area percent tells you the sample is homogeneous. Mass spectrometry tells you what the homogeneous thing is. For a short peptide, the second question is the one worth paying for.